Over the last 7 days, the Clinical Research and Equipment industry has dropped 9.6%, driven by WuXi Biologics (Cayman) declining 17%. Meanwhile, Genscript Biotech actually outperformed within the industry, gaining 20% in the last week. However, the industry is down 59% over the past year. As for the next few years, earnings are expected to grow by 39% per annum.
Has the Hong Kong Clinical Research and Equipment Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Mon, 18 Mar 2024 | HK$120.3b | HK$33.3b | HK$3.7b | 47.6x | 32.7x | 3.6x |
Wed, 14 Feb 2024 | HK$124.0b | HK$32.3b | HK$3.0b | 46.7x | 41.7x | 3.8x |
Fri, 12 Jan 2024 | HK$198.5b | HK$32.4b | HK$3.0b | 91.8x | 66.3x | 6.1x |
Sun, 10 Dec 2023 | HK$208.4b | HK$32.3b | HK$3.0b | 81.4x | 69.7x | 6.4x |
Tue, 07 Nov 2023 | HK$272.9b | HK$30.2b | HK$2.7b | 47.7x | 101.4x | 9x |
Thu, 05 Oct 2023 | HK$245.6b | HK$30.2b | HK$2.7b | 41.7x | 91.8x | 8.1x |
Sat, 02 Sep 2023 | HK$235.0b | HK$30.3b | HK$2.7b | 41.8x | 86.9x | 7.7x |
Mon, 31 Jul 2023 | HK$236.8b | HK$28.5b | HK$2.7b | 23.8x | 86.2x | 8.3x |
Wed, 28 Jun 2023 | HK$209.3b | HK$28.4b | HK$2.7b | 21.2x | 77x | 7.4x |
Fri, 26 May 2023 | HK$235.8b | HK$28.9b | HK$2.8b | 21.9x | 83.6x | 8.1x |
Sun, 23 Apr 2023 | HK$265.7b | HK$29.5b | HK$2.9b | 25.1x | 90.5x | 9x |
Tue, 21 Mar 2023 | HK$238.6b | HK$26.4b | HK$2.1b | 22.9x | 115.6x | 9x |
Thu, 16 Feb 2023 | HK$313.3b | HK$26.5b | HK$2.1b | 25.1x | 149.5x | 11.8x |
Sat, 14 Jan 2023 | HK$378.5b | HK$26.7b | HK$2.2b | 27.6x | 174.2x | 14.2x |
Mon, 12 Dec 2022 | HK$288.2b | HK$26.0b | HK$2.0b | 27.9x | 144.4x | 11.1x |
Wed, 09 Nov 2022 | HK$255.7b | HK$25.6b | HK$1.9b | 24.8x | 137.4x | 10x |
Fri, 07 Oct 2022 | HK$256.4b | HK$25.7b | HK$1.9b | 20.5x | 134.5x | 10x |
Sun, 04 Sep 2022 | HK$343.4b | HK$26.3b | HK$2.1b | 27.3x | 167.1x | 13x |
Tue, 02 Aug 2022 | HK$384.6b | HK$22.3b | HK$2.1b | 12x | 187.6x | 17.2x |
Thu, 30 Jun 2022 | HK$379.0b | HK$22.4b | HK$2.1b | 15.6x | 182.6x | 16.9x |
Sat, 28 May 2022 | HK$284.4b | HK$22.3b | HK$2.1b | 13.1x | 138.4x | 12.7x |
Mon, 25 Apr 2022 | HK$296.8b | HK$22.9b | HK$2.2b | 14.3x | 133.1x | 12.9x |
Wed, 23 Mar 2022 | HK$314.7b | HK$19.2b | HK$1.5b | 21.1x | 205.9x | 16.4x |
Fri, 18 Feb 2022 | HK$350.8b | HK$18.7b | HK$2.8b | 24.4x | 124.3x | 18.7x |
Sun, 16 Jan 2022 | HK$477.6b | HK$18.7b | HK$2.8b | 29.6x | 170.2x | 25.6x |
Tue, 14 Dec 2021 | HK$528.1b | HK$18.7b | HK$2.8b | 37.1x | 188.6x | 28.3x |
Thu, 11 Nov 2021 | HK$536.7b | HK$18.6b | HK$2.8b | 35.4x | 192.2x | 28.9x |
Sat, 09 Oct 2021 | HK$572.2b | HK$18.5b | HK$2.8b | 51.7x | 207.6x | 31x |
Mon, 06 Sep 2021 | HK$628.0b | HK$18.4b | HK$2.7b | 52.9x | 228.9x | 34.1x |
Wed, 04 Aug 2021 | HK$679.8b | HK$18.4b | HK$2.7b | 56x | 247.8x | 37x |
Sat, 08 May 2021 | HK$524.9b | HK$15.7b | HK$1.4b | 47.5x | 363.3x | 33.5x |
320.2x
How does Hong Kong Clinical Research and Equipment compare with similar industries?
HK Market | 1.55% | |
Healthcare | 4.12% | |
Life Sciences | -9.62% | |
Clinical Research and Equipment | -9.62% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
1548 Genscript Biotech | HK$16.74 | 7.9% +HK$2.6b | -9.0% | PS5.4x | |
1873 Viva Biotech Holdings | HK$0.54 | 3.8% +HK$42.8m | -64.5% | PS0.4x |